Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

UltraCor Twirl Breast Tissue Marker

K-Number: K152510 · 2016-05-13

ApplicantBard Peripheral Vascular, Inc.
Decision Date2016-05-13
Product CodeNEU
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

UltraCor Twirl Breast Tissue Marker is a medical device manufactured by Bard Peripheral Vascular, Inc.. It received FDA 510(k) clearance on 2016-05-13 under approval number K152510. The device is classified under product code NEU. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the UltraCor Twirl Breast Tissue Marker?

UltraCor Twirl Breast Tissue Marker is a medical device that received FDA 510(k) clearance on 2016-05-13. It is manufactured by Bard Peripheral Vascular, Inc.. The 510(k) number is K152510.

When was UltraCor Twirl Breast Tissue Marker approved by the FDA?

UltraCor Twirl Breast Tissue Marker received FDA 510(k) clearance on 2016-05-13, under approval number K152510.

What company makes UltraCor Twirl Breast Tissue Marker?

UltraCor Twirl Breast Tissue Marker is manufactured by Bard Peripheral Vascular, Inc..

What is the FDA product code for UltraCor Twirl Breast Tissue Marker?

The FDA product code for UltraCor Twirl Breast Tissue Marker is NEU.

Related Clinical Trials

NCT07607366 Effects of Negative Pressure Wound Bandaging After Mastectomy RECRUITING NCT07594678 Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients NOT_YET_RECRUITING NCT07067138 A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast) SUSPENDED NCT07095569 Shoulder Denervation for Post Mastectomy Irradiation Shoulder Pain RECRUITING NCT07086248 A Study to Determine if RADIESSE® Dilute Treatment in Décolleté of Adult Women Affects Radiographic Imaging Assessments ACTIVE_NOT_RECRUITING NCT05190978 Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction RECRUITING

Other Devices by Bard Peripheral Vascular, Inc.

K161986SIDEKICK and USHER Support Catheters K171953Bard Mission Disposable Core Biopsy Instrument K163420UltraScore Focused Force PTA Balloon K180061UltraCor Twirl Breast Tissue Marker K192948EleVation Breast Biopsy Driver, EleVation Breast Biopsy Probe - 10G, EleVation Breast Biopsy Probe - 14G K192318Ultraverse 014 and 018 PTA Balloon Dilatation Catheters

View all 22 devices →

Related Devices (Code: NEU)

K161021HydroMARK Breast Biopsy Site MarkerDevicor Medical Products, Inc. K171767Cianna Medical SAVI Scout Reflector and SAVI Scout SystemCianna Medical, Inc. K170803HydroMARK Breast Biopsy Site MarkersDevicor Medical Products, Inc. K170026Radiopaque Tissue MarkerViscus Biologics, LLC K170905Star Tissue MarkerScion Medical Technologies, LLC K182082Tumark for Eviva, Tumark for BreveraSomatex Medical Technologies GmbH

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑